Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplant Lymphoproliferative Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02662296
What this trial is testing

Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant

Who this might be right for
Prolymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Non-Hodgkin Lymphoma+1 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02203643
What this trial is testing

Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma.

Who this might be right for
MULTIPLE MYELOMA (MM)
Mario Boccadoro 477
Testing effectiveness (Phase 2)Ended earlyNCT05896163
What this trial is testing

Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.

Who this might be right for
Diffuse Large B-Cell Lymphoma
Pfizer 40
Testing effectiveness (Phase 2)Study completedNCT00458848
What this trial is testing

Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 470
Testing effectiveness (Phase 2)Ended earlyNCT00121186
What this trial is testing

S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 1
Early research (Phase 1)Not Yet RecruitingNCT07518654
What this trial is testing

Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma

Who this might be right for
Leukaemia (Acute Lymphoblastic)Leukaemia (Acute Myeloid)Neuroblastoma+7 more
Michel Duval 12
Testing effectiveness (Phase 2)WithdrawnNCT03393273
What this trial is testing

Elotuzumab in Patients With Multiple Myeloma Before and After Peripheral Stem Cell Autologous Graft

Who this might be right for
Multiple Myeloma
Assistance Publique - Hôpitaux de Paris
Early research (Phase 1)UnknownNCT04516551
What this trial is testing

Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT

Who this might be right for
Relapsed Adult ALLB Cell Leukemia
Xinqiao Hospital of Chongqing 18
Large-scale testing (Phase 3)Study completedNCT02942173
What this trial is testing

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 150
Early research (Phase 1)Not Yet RecruitingNCT06666153
What this trial is testing

Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases

Who this might be right for
CAEBV (Chronic Active Epstein-Barr Virus Infection) SyndromePTLDs
West China Hospital 27
Testing effectiveness (Phase 2)Study completedNCT02900976
What this trial is testing

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

Who this might be right for
EBV-Related Post-Transplant Lymphoproliferative DisorderMonomorphic Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative Disorder+4 more
Children's Oncology Group 18
Testing effectiveness (Phase 2)Study completedNCT01022996
What this trial is testing

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.

Who this might be right for
Hodgkin Lymphoma
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Study completedNCT00064246
What this trial is testing

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder

Who this might be right for
Post-transplant Lymphoproliferative DisorderRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+5 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05364762
What this trial is testing

Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+4 more
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00869323
What this trial is testing

Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders

Who this might be right for
Lymphoproliferative Disorder
Masonic Cancer Center, University of Minnesota 3
Not applicableStudy completedNCT02716103
What this trial is testing

Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 45
Large-scale testing (Phase 3)Study completedNCT00861250
What this trial is testing

Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT

Who this might be right for
Multiple Myeloma
Tampere University Hospital 47
Not applicableUnknownNCT03327285
What this trial is testing

C-CAR011 Treatment in Subjects With ALL After HSCT

Who this might be right for
Acute Lymphoblastic Leukemia(ALL)
Peking University People's Hospital 40
Early research (Phase 1)Study completedNCT03524235
What this trial is testing

Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL

Who this might be right for
Multiple MyelomaCLLChronic Lymphocytic Leukemia+2 more
Noah Merin 20
Not applicableActive Not RecruitingNCT07814170
What this trial is testing

A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In Greece

Who this might be right for
Blood CancersLeukemiaLymphoma+13 more
University of West Attica 80
Next Page